Background Whether guided selection of antiplatelet therapy in patients undergoing
percutaneous coronary intervention (PCI) is effective in improving outcomes compared with …

Since its introduction in 1977, percutaneous coronary intervention has become one of the
most commonly performed therapeutic procedures worldwide. Such widespread diffusion …

The American College of Cardiology (ACC) has a long history of developing documents (eg,
decision pathways, health policy statements, appropriate use criteria) to provide members …

Introduction Clopidogrel is the most frequently utilized P2Y12 inhibitor and is characterized
by broad interindividual response variability resulting in impaired platelet inhibition and …

MicroRNAs (miRNAs) are small, non-coding RNAs, able to regulate cellular functions by
specific gene modifications. Platelets are the major source for circulating miRNAs, with …

Objectives The aim of this study was to determine the risk period for increased stent
thrombosis (ST) after percutaneous coronary intervention (PCI) in patients with acute …

2 McMahan K, Yu J, Mercado NB, et al. Correlates of protection against SARS-CoV-2 in
rhesus macaques. Nature 2021; 590: 630–34. 3 Yu J, Tostanoski LH, Peter L, et al. DNA …

Background Although P2Y 12 inhibitor monotherapy has emerged as a promising
alternative for dual antiplatelet therapy (DAPT), there remains concern regarding the safety …

Background Platelet function testing (PFT) in patients treated with P2Y 12 inhibitors has
been widely evaluated for the prediction of stent thrombosis, myocardial infarction, and …

Background Clopidogrel, prasugrel and ticagrelor, acting on platelet P2Y12 receptor, are
commonly used for prevention of stent thrombosis (ST) among patients who underwent …